CREMS Prostate Biopsy Pain Relief Study
This study has been completed.
Sponsor:
University Health Network, Toronto
Collaborator:
University of Toronto
Information provided by:
University Health Network, Toronto
ClinicalTrials.gov Identifier:
NCT01365871
First received: May 27, 2011
Last updated: January 17, 2012
Last verified: January 2012
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
The current standard for pain relief during prostate biopsy is the injection of local anesthetic agents into or around the prostate at various sites including apex, base, lateral aspects and into the prostate itself. Despite such anesthetic injection, some men still experience severe pain and often at the base of the penis. The study audits current practices comparing the degree of pain relief provided by injection at basal versus basal+apical sites. All these injection sites are standard practice at our hospital.
| Condition | Intervention |
|---|---|
|
Pain |
Procedure: anesthetics injection |
| Study Type: | Interventional |
| Study Design: | Allocation: Randomized Endpoint Classification: Efficacy Study Intervention Model: Parallel Assignment Masking: Open Label Primary Purpose: Prevention |
| Official Title: | Pain Relief With Local Anesthetic at Time of Prostate Biopsy: Comparing Apical and Basal Injection Versus Basal Injection Alone |
Further study details as provided by University Health Network, Toronto:
Primary Outcome Measures:
- Pain scores comparing two groups. [ Time Frame: post prostate biopsy procedure up to 6 months ] [ Designated as safety issue: No ]Pain questionnaires will be asked to filled in before the procedure, within 20 minutes of the procedure, at 2-4 weeks and at 6-month post procedure.
Secondary Outcome Measures:
- Incidence of side effects and complications. [ Time Frame: post prostate biopsy procedure up to 6 months ] [ Designated as safety issue: Yes ]Questionnaires will be asked to filled in to assess side effects and complications at 2-4 weeks and at 6-month post procedure.
| Enrollment: | 300 |
| Study Start Date: | June 2011 |
| Study Completion Date: | December 2011 |
| Primary Completion Date: | December 2011 (Final data collection date for primary outcome measure) |
| Arms | Assigned Interventions |
|---|---|
|
Active Comparator: basal injection
basal injection of anesthetics
|
Procedure: anesthetics injection
Basal injection of anesthetics or basal + apical injection of anesthetics.
|
|
Active Comparator: basal + apical injection
basal + apical injection of anesthetics
|
Procedure: anesthetics injection
Basal injection of anesthetics or basal + apical injection of anesthetics.
|
Eligibility| Ages Eligible for Study: | 30 Years and older |
| Genders Eligible for Study: | Male |
| Accepts Healthy Volunteers: | No |
Criteria
Inclusion Criteria:
- Men who come for prostate biopsy
Exclusion Criteria:
- Men who are unwilling or unable to consent and fill in the forms
Contacts and Locations
More Information
No publications provided
| Responsible Party: | Dr. Ants Toi, University Health Network, Toronto, Ontario, Canada |
| ClinicalTrials.gov Identifier: | NCT01365871 History of Changes |
| Other Study ID Numbers: | TOI-CREMS |
| Study First Received: | May 27, 2011 |
| Last Updated: | January 17, 2012 |
| Health Authority: | Canada: Health Canada |
Keywords provided by University Health Network, Toronto:
|
prostate biopsy pain |
Additional relevant MeSH terms:
|
Anesthetics Central Nervous System Depressants Physiological Effects of Drugs |
Pharmacologic Actions Central Nervous System Agents Therapeutic Uses |
ClinicalTrials.gov processed this record on May 23, 2013